Johnson & Johnson said on Tuesday its chemotherapy-free combination treatment showed a meaningful improvement in extending ...
Zacks.com on MSN5d
AstraZeneca Stock Down Almost 14% in 3 Months: Time to Sell?AZN's key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Fasenra are likely to drive sales. It has several candidates ...
Analysis of AstraZeneca's market potential, including China and IRA impacts, and the importance of key readouts in 2025 for ...
SAN DIEGO, CA / ACCESSWIRE / January 9, 2025 / Robbins LLP reminds investors that a class action was filed on behalf of all ...
AstraZeneca PLC (AZN) stock saw a modest uptick, ending the day at $67.01 which represents a slight increase of $0.43 or 0.65% from the prior close of $66.58. The stock opened at $67.19 and touched a ...
AstraZeneca (AZN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Sachin Jain from Bank ...
Novo Nordisk (NYSE: NVO) and AstraZeneca (NASDAQ: AZN) are among the largest companies in the pharmaceutical industry. Both ...
This complaint was first surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign ...
Finally, the AstraZeneca class action lawsuit alleges that on December 18, 2024, Financial Times published an article ...
AstraZeneca PLC AZN shares inched down 0.41% to £106.68 Tuesday, on what proved to be an all-around rough trading session for ...
AstraZeneca has been taking a wider role in Vietnam’s healthcare sector to help expand access to quality healthcare.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback